These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 15865100

  • 1. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for cancer screening in healthy subjects.
    Chen YK, Ding HJ, Chen KT, Chen YL, Liao AC, Shen YY, Su CT, Kao CH.
    Anticancer Res; 2005; 25(2B):1421-6. PubMed ID: 15865100
    [Abstract] [Full Text] [Related]

  • 2. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects.
    Kang KW, Kim SK, Kang HS, Lee ES, Sim JS, Lee IG, Jeong SY, Kim SW.
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4100-4. PubMed ID: 12970270
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization.
    Choi JY, Lee KS, Kim HJ, Shim YM, Kwon OJ, Park K, Baek CH, Chung JH, Lee KH, Kim BT.
    J Nucl Med; 2006 Apr; 47(4):609-15. PubMed ID: 16595494
    [Abstract] [Full Text] [Related]

  • 6. Thyroid incidentaloma identified by ¹⁸F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance.
    Pagano L, Samà MT, Morani F, Prodam F, Rudoni M, Boldorini R, Valente G, Marzullo P, Baldelli R, Appetecchia M, Isidoro C, Aimaretti G.
    Clin Endocrinol (Oxf); 2011 Oct; 75(4):528-34. PubMed ID: 21575027
    [Abstract] [Full Text] [Related]

  • 7. The role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography whole body imaging in the evaluation of focal thyroid incidentaloma.
    Zhai G, Zhang M, Xu H, Zhu C, Li B.
    J Endocrinol Invest; 2010 Mar; 33(3):151-5. PubMed ID: 19783895
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Risk of malignancy in thyroid incidentalomas detected by 18F-fluorodeoxyglucose positron emission tomography: a systematic review.
    Soelberg KK, Bonnema SJ, Brix TH, Hegedüs L.
    Thyroid; 2012 Sep; 22(9):918-25. PubMed ID: 22827552
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Risk stratification and prediction of cancer of focal thyroid fluorodeoxyglucose uptake during cancer evaluation.
    Kim BH, Na MA, Kim IJ, Kim SJ, Kim YK.
    Ann Nucl Med; 2010 Dec; 24(10):721-8. PubMed ID: 20830537
    [Abstract] [Full Text] [Related]

  • 13. Thyroid incidentalomas discovered on positron emission tomography CT scanning - Malignancy rate and significance of standardised uptake values.
    Brindle R, Mullan D, Yap BK, Gandhi A.
    Eur J Surg Oncol; 2014 Nov; 40(11):1528-32. PubMed ID: 24915858
    [Abstract] [Full Text] [Related]

  • 14. Colorectal cancer screening in asymptomatic adults: the role of FDG PET scan.
    Chen YK, Kao CH, Liao AC, Shen YY, Su CT.
    Anticancer Res; 2003 Nov; 23(5b):4357-61. PubMed ID: 14666651
    [Abstract] [Full Text] [Related]

  • 15. Clinical significance of standardized uptake values in thyroid incidentaloma discovered by F-18 fluorodeoxyglucose positron emission tomography/computed tomography.
    Sager S, Vatankulu B, Sahin OE, Cınaral F, Uslu L, Baran A, Ozturk T, Sönmezoglu K.
    J Cancer Res Ther; 2018 Nov; 14(5):989-993. PubMed ID: 30197336
    [Abstract] [Full Text] [Related]

  • 16. Thyroid incidentalomas on 18FDG-PET/CT: a metabolico-pathological correlation.
    Hagenimana N, Dallaire J, Vallée É, Belzile M.
    J Otolaryngol Head Neck Surg; 2017 Mar 21; 46(1):22. PubMed ID: 28320460
    [Abstract] [Full Text] [Related]

  • 17. Focal uptake of fluorodeoxyglucose by the thyroid in patients undergoing initial disease staging with combined PET/CT for non-small cell lung cancer.
    Yi JG, Marom EM, Munden RF, Truong MT, Macapinlac HA, Gladish GW, Sabloff BS, Podoloff DA.
    Radiology; 2005 Jul 21; 236(1):271-5. PubMed ID: 15987980
    [Abstract] [Full Text] [Related]

  • 18. Incidental thyroid lesions on FDG-PET/CT: a prevalence study and proposition of management.
    Adas M, Adas G, Koc B, Ozulker F.
    Minerva Endocrinol; 2015 Sep 21; 40(3):169-75. PubMed ID: 26205646
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical significance of focal and diffuse thyroid diseases identified by (18)F-fluorodeoxyglucose positron emission tomography.
    Salvatori M, Melis L, Castaldi P, Maussier ML, Rufini V, Perotti G, Rubello D.
    Biomed Pharmacother; 2007 Sep 21; 61(8):488-93. PubMed ID: 17604940
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.